ULTRAGENYX PHARMACEUTICAL
Dead / Cancelled — Cancelled — Section 8 (as of 28 Jul 2023)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85898928
- Registration number
- 5124555
- Mark type
- Word mark
- Filed
- 09 Apr 2013
- Published for opposition
- 08 Oct 2013
- Registered
- 17 Jan 2017
- Attorney of record
- Anne H. Peck
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of genetic, neuro-muscular, osteopathic, neurologic, oncologic, metabolic, orthopedic, endocrine, and lipid-related conditions, diseases and disorders
Owner
- Ultragenyx Pharmaceutical Inc., Novato, CA, US
- Ultragenyx Pharmaceutical Inc., Novato, CA, US
- Ultragenyx Pharmaceutical Inc., Novato, CA, US
Prosecution history
- 28 Jul 2023 — CANCELLED SEC. 8 (6-YR)
- 17 Jan 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Jan 2017 — REGISTERED-PRINCIPAL REGISTER
- 16 Dec 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Dec 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Dec 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Dec 2016 — USE AMENDMENT FILED
- 05 Dec 2016 — TEAS STATEMENT OF USE RECEIVED
- 24 May 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 May 2016 — SOU EXTENSION 5 GRANTED
- 06 May 2016 — SOU EXTENSION 5 FILED
- 06 May 2016 — SOU TEAS EXTENSION RECEIVED
- 14 Jan 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jan 2016 — SOU EXTENSION 4 GRANTED
- 13 Nov 2015 — SOU EXTENSION 4 FILED